A3 Adenosine Receptor: A Plausible Therapeutic Target for Cardio-Protection in Diabetes

E-ISSN： 2212-3962|7|1|59-70

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.7, Iss.1, 2012-04, pp. : 59-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine A₃ Receptor: A promising therapeutic target in cardiovascular disease

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-02 ,pp. : 18-26

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine A₃ Receptor: A promising therapeutic target in cardiovascular disease

Current Cardiology Reviews, Vol. 12, Iss. 1, 2016-01 ,pp. : 18-26

Bentham Science Publishers

Access to resources Recommend Favorite

Beta cell mass in diabetes: a realistic therapeutic target?

By Meier J.

Diabetologia, Vol. 51, Iss. 5, 2008-05 ,pp. : 703-713

Springer Publishing Company

Access to resources Recommend Favorite

Mineralocorticoid Receptor Blockade in the Protection of Target Organ Damage

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 4, Iss. 1, 2006-01 ,pp. : 75-91

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiomyocyte Resistance to Doxorubicin Mediated by A₃ Adenosine Receptor

By Shneyvays V. Mamedova L.K. Korkus A. Shainberg A.

Journal of Molecular and Cellular Cardiology, Vol. 34, Iss. 5, 2002-05 ,pp. : 493-507

Academic Press

Access to resources Recommend Favorite